CN Stock MarketDetailed Quotes

002262 Jiangsu Nhwa Pharmaceutical

Watchlist
  • 24.15
  • -0.22-0.90%
Not Open May 15 15:00 CST
24.33BMarket Cap22.63P/E (TTM)

Jiangsu Nhwa Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
15.16%1.36B
17.28%5.04B
17.17%3.66B
19.95%2.4B
18.76%1.18B
9.22%4.3B
7.89%3.12B
7.30%2B
9.79%992.59M
17.09%3.94B
Operating revenue
15.16%1.36B
17.28%5.04B
17.17%3.66B
19.95%2.4B
18.76%1.18B
9.22%4.3B
7.89%3.12B
7.30%2B
9.79%992.59M
17.09%3.94B
Other operating revenue
----
50.93%65.63M
----
57.57%24.19M
----
163.08%43.49M
----
54.39%15.35M
----
-2.73%16.53M
Total operating cost
13.97%1.04B
16.47%3.91B
16.38%2.66B
18.76%1.77B
15.57%909.69M
10.65%3.36B
9.08%2.29B
9.88%1.49B
11.70%787.12M
19.87%3.04B
Operating cost
26.18%396.71M
34.24%1.37B
33.67%983.16M
30.36%630.18M
28.47%314.4M
13.72%1.02B
4.31%735.53M
7.08%483.43M
22.51%244.73M
9.15%897.33M
Operating tax surcharges
11.40%18.67M
18.34%68M
17.95%49.28M
24.11%32.98M
17.60%16.76M
6.34%57.46M
6.65%41.78M
5.50%26.57M
14.82%14.25M
18.48%54.04M
Operating expense
3.88%437.03M
4.96%1.74B
1.51%1.1B
9.54%782.57M
8.13%420.69M
3.78%1.65B
7.21%1.08B
8.95%714.4M
0.19%389.05M
21.73%1.59B
Administration expense
-6.60%47.34M
7.55%207.12M
9.84%151.54M
14.99%94.61M
26.90%50.68M
29.75%192.57M
23.58%137.95M
8.31%82.28M
1.06%39.94M
11.65%148.41M
Financial expense
-152.06%-6.36M
7.33%-19.26M
-72.43%-9.93M
5.48%-4M
-50.77%-2.52M
-98.91%-20.78M
26.42%-5.76M
21.69%-4.23M
42.28%-1.67M
56.44%-10.45M
-Interest expense (Financial expense)
157.65%1.19M
-15.84%4.16M
216.29%3.19M
214.01%2.28M
7.26%460.24K
-2.20%4.95M
-14.87%1.01M
-10.09%726.54K
11.61%429.09K
218.34%5.06M
-Interest Income (Financial expense)
-107.29%-8.09M
6.73%-23.81M
-33.49%-13.86M
10.06%-6.64M
-19.09%-3.9M
-44.26%-25.53M
16.06%-10.38M
13.00%-7.38M
18.27%-3.28M
34.04%-17.7M
Research and development
30.77%143.42M
20.93%549.32M
32.11%384.71M
24.23%237.78M
8.77%109.68M
29.15%454.25M
23.80%291.21M
22.24%191.4M
49.23%100.83M
43.06%351.73M
Credit Impairment Loss
-42.32%-23.72M
-321.55%-15.11M
-110.07%-13.44M
-316.86%-17.29M
-802.53%-16.66M
52.66%-3.58M
21.16%-6.4M
47.76%-4.15M
139.89%2.37M
-17,191.78%-7.57M
Asset Impairment Loss
19.35%-6.4M
-105.50%-33.27M
-87.72%-19.25M
-181.21%-11.58M
-536.52%-7.94M
54.20%-16.19M
70.92%-10.26M
87.06%-4.12M
7.40%-1.25M
-61.72%-35.35M
Other net revenue
-110.81%-15.89M
-17.11%52.86M
-33.98%9.53M
-101.55%-114.53K
-278.53%-7.54M
147.18%63.77M
190.37%14.43M
135.40%7.38M
167.22%4.22M
-5.29%25.8M
Invest income
-28.24%11.39M
40.72%51.04M
26.34%37.31M
71.82%25.24M
475.22%15.87M
0.13%36.27M
12.31%29.53M
-19.48%14.69M
478.74%2.76M
68.56%36.23M
-Including: Investment income associates
-17.93%4.22M
110.15%9.64M
-0.38%5.4M
540,591.14%1.46M
346.32%5.14M
246.03%4.59M
178.76%5.42M
-99.98%269.73
21.32%-2.09M
-68.24%1.33M
Asset deal income
-104.45%-1.35K
-60.59%147.23K
-241.40%-215.58K
-80.05%30.34K
--30.34K
255.40%373.54K
625.74%152.45K
8,121.04%152.07K
----
-61.57%-240.38K
Other revenue
143.41%2.85M
6.71%50.05M
266.91%5.12M
334.88%3.48M
246.56%1.17M
43.29%46.9M
21.39%1.39M
21.62%800.39K
-37.30%337.51K
17.74%32.73M
Operating profit
16.55%304.87M
17.83%1.18B
18.44%1.01B
21.66%626.09M
24.74%261.58M
8.38%1B
8.74%848.89M
6.17%514.63M
8.57%209.69M
8.14%925.87M
Add:Non operating Income
278.31%1.82M
166.72%6.75M
-40.39%635.76K
-122.14%-122.09K
-3,940.42%-1.02M
-17.46%2.53M
-10.05%1.07M
-40.60%551.55K
-105.32%-25.3K
228.16%3.06M
Less:Non operating expense
238.16%6.96M
27.09%20.45M
-8.23%5.32M
3.89%3.98M
42.44%2.06M
22.29%16.09M
-34.05%5.79M
-48.68%3.83M
-9.98%1.44M
99.63%13.16M
Total profit
15.95%299.74M
18.06%1.17B
18.55%1B
21.64%621.99M
24.15%258.5M
8.09%989.91M
9.19%844.16M
6.94%511.35M
8.44%208.22M
7.68%915.78M
Less:Income tax cost
5.31%35.1M
22.38%134.4M
8.36%117.36M
14.05%77.58M
55.13%33.33M
-6.74%109.82M
5.75%108.31M
0.87%68.02M
-16.67%21.48M
-4.56%117.75M
Net profit
17.53%264.64M
17.52%1.03B
20.05%883.41M
22.80%544.41M
20.58%225.17M
10.28%880.09M
9.72%735.85M
7.93%443.32M
12.34%186.74M
9.75%798.02M
Net profit from continuing operation
17.53%264.64M
17.52%1.03B
----
22.80%544.41M
--225.17M
10.28%880.09M
----
7.93%443.32M
----
9.75%798.02M
Less:Minority Profit
71.48%-643.47K
87.05%-2.67M
63.03%-2.23M
92.95%-294.62K
-15.80%-2.26M
-8,547.33%-20.62M
-168.95%-6.02M
-2,340.01%-4.18M
-24.71%-1.95M
114.21%244.12K
Net profit of parent company owners
16.64%265.28M
15.12%1.04B
19.38%885.64M
21.72%544.7M
20.53%227.43M
12.90%900.71M
10.25%741.87M
8.91%447.5M
12.45%188.69M
9.46%797.78M
Earning per share
Basic earning per share
13.04%0.26
15.73%1.03
18.92%0.88
22.73%0.54
21.05%0.23
12.66%0.89
10.48%0.74
7.32%0.44
11.76%0.19
9.72%0.79
Diluted earning per share
13.04%0.26
15.73%1.03
18.92%0.88
22.73%0.54
21.05%0.23
12.66%0.89
10.48%0.74
7.32%0.44
11.76%0.19
9.72%0.79
Other composite income
-395.00%-6.35M
151.94%2.15M
-132.51%-4.14M
Other composite income of parent company owners
----
-395.00%-6.35M
----
----
----
151.94%2.15M
----
----
----
-132.51%-4.14M
Total composite income
17.53%264.64M
16.51%1.03B
20.05%883.41M
22.80%544.41M
20.58%225.17M
11.13%882.24M
9.72%735.85M
7.93%443.32M
12.34%186.74M
7.30%793.88M
Total composite income of parent company owners
16.64%265.28M
14.14%1.03B
19.38%885.64M
21.72%544.7M
20.53%227.43M
13.76%902.86M
10.25%741.87M
8.91%447.5M
12.45%188.69M
7.02%793.63M
Total composite income of minority owners
71.48%-643.47K
87.05%-2.67M
63.03%-2.23M
92.95%-294.62K
-15.80%-2.26M
-8,547.33%-20.62M
-168.95%-6.02M
-2,340.01%-4.18M
-24.71%-1.95M
114.21%244.12K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 15.16%1.36B17.28%5.04B17.17%3.66B19.95%2.4B18.76%1.18B9.22%4.3B7.89%3.12B7.30%2B9.79%992.59M17.09%3.94B
Operating revenue 15.16%1.36B17.28%5.04B17.17%3.66B19.95%2.4B18.76%1.18B9.22%4.3B7.89%3.12B7.30%2B9.79%992.59M17.09%3.94B
Other operating revenue ----50.93%65.63M----57.57%24.19M----163.08%43.49M----54.39%15.35M-----2.73%16.53M
Total operating cost 13.97%1.04B16.47%3.91B16.38%2.66B18.76%1.77B15.57%909.69M10.65%3.36B9.08%2.29B9.88%1.49B11.70%787.12M19.87%3.04B
Operating cost 26.18%396.71M34.24%1.37B33.67%983.16M30.36%630.18M28.47%314.4M13.72%1.02B4.31%735.53M7.08%483.43M22.51%244.73M9.15%897.33M
Operating tax surcharges 11.40%18.67M18.34%68M17.95%49.28M24.11%32.98M17.60%16.76M6.34%57.46M6.65%41.78M5.50%26.57M14.82%14.25M18.48%54.04M
Operating expense 3.88%437.03M4.96%1.74B1.51%1.1B9.54%782.57M8.13%420.69M3.78%1.65B7.21%1.08B8.95%714.4M0.19%389.05M21.73%1.59B
Administration expense -6.60%47.34M7.55%207.12M9.84%151.54M14.99%94.61M26.90%50.68M29.75%192.57M23.58%137.95M8.31%82.28M1.06%39.94M11.65%148.41M
Financial expense -152.06%-6.36M7.33%-19.26M-72.43%-9.93M5.48%-4M-50.77%-2.52M-98.91%-20.78M26.42%-5.76M21.69%-4.23M42.28%-1.67M56.44%-10.45M
-Interest expense (Financial expense) 157.65%1.19M-15.84%4.16M216.29%3.19M214.01%2.28M7.26%460.24K-2.20%4.95M-14.87%1.01M-10.09%726.54K11.61%429.09K218.34%5.06M
-Interest Income (Financial expense) -107.29%-8.09M6.73%-23.81M-33.49%-13.86M10.06%-6.64M-19.09%-3.9M-44.26%-25.53M16.06%-10.38M13.00%-7.38M18.27%-3.28M34.04%-17.7M
Research and development 30.77%143.42M20.93%549.32M32.11%384.71M24.23%237.78M8.77%109.68M29.15%454.25M23.80%291.21M22.24%191.4M49.23%100.83M43.06%351.73M
Credit Impairment Loss -42.32%-23.72M-321.55%-15.11M-110.07%-13.44M-316.86%-17.29M-802.53%-16.66M52.66%-3.58M21.16%-6.4M47.76%-4.15M139.89%2.37M-17,191.78%-7.57M
Asset Impairment Loss 19.35%-6.4M-105.50%-33.27M-87.72%-19.25M-181.21%-11.58M-536.52%-7.94M54.20%-16.19M70.92%-10.26M87.06%-4.12M7.40%-1.25M-61.72%-35.35M
Other net revenue -110.81%-15.89M-17.11%52.86M-33.98%9.53M-101.55%-114.53K-278.53%-7.54M147.18%63.77M190.37%14.43M135.40%7.38M167.22%4.22M-5.29%25.8M
Invest income -28.24%11.39M40.72%51.04M26.34%37.31M71.82%25.24M475.22%15.87M0.13%36.27M12.31%29.53M-19.48%14.69M478.74%2.76M68.56%36.23M
-Including: Investment income associates -17.93%4.22M110.15%9.64M-0.38%5.4M540,591.14%1.46M346.32%5.14M246.03%4.59M178.76%5.42M-99.98%269.7321.32%-2.09M-68.24%1.33M
Asset deal income -104.45%-1.35K-60.59%147.23K-241.40%-215.58K-80.05%30.34K--30.34K255.40%373.54K625.74%152.45K8,121.04%152.07K-----61.57%-240.38K
Other revenue 143.41%2.85M6.71%50.05M266.91%5.12M334.88%3.48M246.56%1.17M43.29%46.9M21.39%1.39M21.62%800.39K-37.30%337.51K17.74%32.73M
Operating profit 16.55%304.87M17.83%1.18B18.44%1.01B21.66%626.09M24.74%261.58M8.38%1B8.74%848.89M6.17%514.63M8.57%209.69M8.14%925.87M
Add:Non operating Income 278.31%1.82M166.72%6.75M-40.39%635.76K-122.14%-122.09K-3,940.42%-1.02M-17.46%2.53M-10.05%1.07M-40.60%551.55K-105.32%-25.3K228.16%3.06M
Less:Non operating expense 238.16%6.96M27.09%20.45M-8.23%5.32M3.89%3.98M42.44%2.06M22.29%16.09M-34.05%5.79M-48.68%3.83M-9.98%1.44M99.63%13.16M
Total profit 15.95%299.74M18.06%1.17B18.55%1B21.64%621.99M24.15%258.5M8.09%989.91M9.19%844.16M6.94%511.35M8.44%208.22M7.68%915.78M
Less:Income tax cost 5.31%35.1M22.38%134.4M8.36%117.36M14.05%77.58M55.13%33.33M-6.74%109.82M5.75%108.31M0.87%68.02M-16.67%21.48M-4.56%117.75M
Net profit 17.53%264.64M17.52%1.03B20.05%883.41M22.80%544.41M20.58%225.17M10.28%880.09M9.72%735.85M7.93%443.32M12.34%186.74M9.75%798.02M
Net profit from continuing operation 17.53%264.64M17.52%1.03B----22.80%544.41M--225.17M10.28%880.09M----7.93%443.32M----9.75%798.02M
Less:Minority Profit 71.48%-643.47K87.05%-2.67M63.03%-2.23M92.95%-294.62K-15.80%-2.26M-8,547.33%-20.62M-168.95%-6.02M-2,340.01%-4.18M-24.71%-1.95M114.21%244.12K
Net profit of parent company owners 16.64%265.28M15.12%1.04B19.38%885.64M21.72%544.7M20.53%227.43M12.90%900.71M10.25%741.87M8.91%447.5M12.45%188.69M9.46%797.78M
Earning per share
Basic earning per share 13.04%0.2615.73%1.0318.92%0.8822.73%0.5421.05%0.2312.66%0.8910.48%0.747.32%0.4411.76%0.199.72%0.79
Diluted earning per share 13.04%0.2615.73%1.0318.92%0.8822.73%0.5421.05%0.2312.66%0.8910.48%0.747.32%0.4411.76%0.199.72%0.79
Other composite income -395.00%-6.35M151.94%2.15M-132.51%-4.14M
Other composite income of parent company owners -----395.00%-6.35M------------151.94%2.15M-------------132.51%-4.14M
Total composite income 17.53%264.64M16.51%1.03B20.05%883.41M22.80%544.41M20.58%225.17M11.13%882.24M9.72%735.85M7.93%443.32M12.34%186.74M7.30%793.88M
Total composite income of parent company owners 16.64%265.28M14.14%1.03B19.38%885.64M21.72%544.7M20.53%227.43M13.76%902.86M10.25%741.87M8.91%447.5M12.45%188.69M7.02%793.63M
Total composite income of minority owners 71.48%-643.47K87.05%-2.67M63.03%-2.23M92.95%-294.62K-15.80%-2.26M-8,547.33%-20.62M-168.95%-6.02M-2,340.01%-4.18M-24.71%-1.95M114.21%244.12K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg